Role of iodine, selenium and other micronutrients in thyroid function and disorders

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 9, Issue 3, 2009, Pages 277-294

  Triggiani, Vincenzo ^a   Tafaro, Emilio ^a   Giagulli, Vito Angelo ^b   Sabbà, Carlo ^a   Resta, Francesco ^a   Licchelli, Brunella ^a   Guastamacchia, Edoardo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Department of Internal Medicine Metabolic Diseases and Diabetes ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; SELENIUM; THYROID HORMONE; TRACE ELEMENT; VEGETABLE OIL;

DEVELOPING COUNTRY; DEVELOPMENTAL DISORDER; DIET SUPPLEMENTATION; DIETARY INTAKE; GOITER; GROWTH DISORDER; HORMONE DEFICIENCY; HUMAN; HYPERTENSION; HYPOTHYROIDISM; IODINE DEFICIENCY; MENTAL DEFICIENCY; NUTRIENT; REVIEW; SALT INTAKE; THYROID DISEASE; THYROID FUNCTION; THYROID HORMONE SYNTHESIS; ANIMAL; PHYSIOLOGY; THYROID GLAND;

ANIMALS; HUMANS; IODINE; MICRONUTRIENTS; SELENIUM; THYROID DISEASES; THYROID GLAND;

EID: 70350478407     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/187153009789044392     Document Type: Review

References (314)

1. Hetzel, B.S. and Clugston, G.A. (1999) Iodine. in: Nutrition in Health and Disease; (Shils, M.; Olson, J.A.; Shike, M.; Ross, A.C. Eds.) Baltimore: Williams & Wilkins, Vol. 9, pp. 253-264.
2. Dunn, J.T. (1998) What's happening to our iodine? J. Clin. Endocrinol. Metab., 83(10), 3398-3400.
3. Larsen, P.R.; Davies, T.F.; Hay, I.D. (1998) The thyroid gland. in: Williams Textbook of Endocrinology. (Wilson, J.D.; Foster, D.W.; Kronenberg, H.M.; Larsen, P.R. Eds.) 9th ed; Philadelphia: W.B. Saunders Company, pp. 389-515.
4. DeGroot L.J. (1966) Kinetic analysis of iodine metabolism. J. Clin. Endocrinol. Metab., 26(2), 149-173.
5. McConahey, W.M.; Keating, F.R.; Power, M.H. (1951) An estimation of the renal and extrarenal clearance of radioiodine in man. J. Clin. Invest., 30, 778.
6. Bricker, N.S. and Hlad, C.J. Jr. (1955) Observations on the mechanism of the renal clearance of l131. J. Clin. Invest., 34(7, Part 1), 1057-1072.
7. Perry, W.F. and Hughes, J.F.S. (1952) The urinary excretion and thyroid uptake of iodine in renal disease. J. Clin. Invest., 31(5), 457-463.
8. Berson, S.A.; Yalow, R.S.; Sorrentino, J. and Roswit, B. (1952) The determination of thyroidal and renal plasma I131 clearance rates as a routine diagnostic test of thyroid dysfunction. J. Clin. Invest., 31(2), 141-158.
9. Pochin, E.E. (1950) Investigation of thyroid function and disease with radioactive iodine. Lancet, 2(6620), 84-91.
10. Berson, S.A. and Yalow, R.S. (1955) The iodide trapping and binding functions of the thyroid. J. Clin. Invest., 34(2), 186-204.
11. Brunberg, J.A. and Halmi, N.S. (1966) The role of ouabainsensitive adenosine triphosphatase in the stimulating effect of thyrotropin on the iodide pump of the rat thyroid. Endocrinology, 79(4), 801-807.
12. Kogai, T.; Endo, T.; Saito, T.; Miyazaki, A.; Kawaguchi, A. and Onaya, T. (1997) Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology, 138(6), 2227-2232.
13. Rodriguez, A.M.; Perron, B.; Lacroix, L.; Caillou, B.; Leblanc, G.; Schlumberger, M.; Bidart, J.M. and Pourcher, T. (2002) Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J. Clin. Endocrinol. Metab., 87(7), 3500-3503.
14. Royaux, I.E.; Suzuki, K.; Mori, A.; Katoh, R.; Everett, L.A.; Kohn, L.D. and Green, E.D. (2000) Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology, 141(2), 839-845.
15. Yoshida, A.; Taniguchi, S.; Hisatome, I.; Royaux, I.E.; Green, E.D.; Kohn, L.D. and Suzuki, K. (2002) Pendrin is an iodide-specific apical porter responsible for iodide efflux from thyroid cells. J. Clin. Endocrinol. Metab., 87(7), 3356-3361.
16. Wolff, J. and Chaikoff, I.L. (1948) Plasma inorganic iodide as a homeostatic regulator of thyroid function. J. Biol. Chem., 174(2), 555-564.
17. Saito, T.; Endo, T.; Kawaguchi, A.; Ikeda, M.; Nakazato, M.; Kogai, T. and Onaya, T. (1997) Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue. J. Clin. Endocrinol. Metab., 82(10), 3331-3316.
18. Eng, P.H.; Cardona, G.R.; Fang, S.L.; Previti, M.; Alex, S.; Carrasco, N.; Chin, W.W. and Braverman, L.E. (1999) Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology, 140(8), 3404-3410.
19. Lazar, V.; Bidart, J.M.; Caillou, B.; Mahe, C.; Lacroix, L.; Filetti, S. and Schlumberger, M. (1999) Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J. Clin. Endocrinol. Metab., 84(9), 3228-3234.
20. Jhiang, S.M.; Cho, J.Y.; Ryu, K.Y.; DeYoung, B.R.; Smanik, P.A.; McGaughy, V.R.; Fischer, A.H. and Mazzaferri, E.L. (1998) An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues. Endocrinology, 139(10), 4416-4419.
21. Tazebay, U.H.; Wapnir, I.L.; Levy, O.; Dohan, O.; Zuckier, L.S.; Zhao, Q.H.; Deng, H.F.; Amenta, P.S.; Fineberg, S.; Pestell, R.G. and Carrasco, N. (2000) The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat. Med., 6(8), 871-878.
22. Cho, J.Y.; Léveillé, R.; Kao, R.; Rousset, B.; Parlow, A.F.; Burak, W.E.Jr.; Mazzaferri, E.L. and Jhiang, S.M. (2000) Hormonal regulation of radioiodide uptake activity and Na+/I- symporter expression in mammary glands. J. Clin. Endocrinol. Metab., 85(8), 2936-2943.
23. Delange, F. and Requirements of iodine in humans. (1993) In: Iodine Deficiency in Europe. A Continuing Concern. Eds: Delange F, Dunn JT, Glinoer D. Plenum Press, New York, pp 5-13.
24. De Deken, X.; Wang, D.; Dumont, J.E. and Miot, F. (2002) Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system. Exp. Cell Res., 273(2), 187-196.
25. Caillou, B.; Dupuy, C.; Lacroix, L.; Nocera, M.; Talbot, M.; Ohayon, R.; Deme, D.; Bidart, J.M.; Schlumberger, M. and Virion, A. (2001) Expression of reduced nicotinamide adenine dinucleotide phosphate oxidase (ThoX, LNOX, Duox) genes and proteins in human thyroid tissues. J. Clin. Endocrinol. Metab., 86(7), 3351-3358.
26. Corvilain, B.; Van Sande, J.; Laurent, E. and Dumont, J.E. (1991) The H2O2-generating system modulates protein iodination and the activity of the pentose phosphate pathway in dog thyroid. Endocrinology, 128(2), 779-785.
27. Corvilain, B.; Laurent, E.; Lecomte, M.; Vansande, J. and Dumont, J.E. (1994) Role of the cyclic adenosine 3',5'-monophosphate and the phosphatidylinositol-Ca2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. J. Clin. Endocrinol. Metab., 79(1), 152-159.
28. Farber, J.L.; Kyle, M.E. and Coleman, J.B. (1990) Mechanisms of cell injury by activated oxygen species. Lab Invest., 62(6), 670-679.
29. 2 in isolated porcine thyroid follicles. Endocrinology, 115(1), 392-398.
30. Rotruck, J.T.; Pope, A.L.; Ganther, H.E.; Swanson, A.B.; Hafeman, D.G. and Hoekstra, W.G. (1973) Selenium: biochemical role as a component of glutathione peroxidase. Science, 179(73), 588-590.
31. Flohé, L.; Günzler, W. and Schock, H.H. (1973) Glutathione peroxidase: a selenoenzyme. FEBS Lett., 32(1), 132-134.
32. Goyens, P.; Golstein, J.; Nsombola, B.; Vis, H. and Dumont, J.E. (1987) Selenium deficiency as a possible factor in the pathogenesis of myxoedematous endemic cretinism. Acta. Endocrinol. (Copenh)., 114(4), 497-502.
33. Levander, O.A. (1992) Selenium and sulfur in antioxidant protective systems: relationships with vitamin E and malaria. Proc. Soc. Exp. Biol. Med., 200(2), 255-259.
34. Ursini, F.; Maiorino, M. and Gregolin, C. (1985) The selenoenzyme phospholipid hydroperoxide glutathione peroxidase. Biochim. Biophys. Acta, 839(1), 62-70.
35. Roveri, A.; Casasco, A.; Maiorino, M.; Dalan, P.; Calligaro, A. and Urini, F. (1992) Phospholipid hydroperoxide glutathione peroxidase of rat testis. Gonadotropin dependence and immunocytochemical identification. J. Biol. Chem., 267(9), 6142-6146.
36. Björkman, U. and Ekholm, R. (1995) Hydrogen peroxide degradation and glutathione peroxidase activity in cultures of thyroid cells. Mol. Cell Endocrinol., 111(1), 99-107.
37. Fisher, D.A.; Oddie, T.H. and Thompson, C.S. (1971) Thyroidal thyronine and non-thyronine iodine secretion in euthyroid subjects. J. Clin. Endocrinol. Metab., 33(4), 647-652.
38. Fuge, R. and Johnson, C.J. (1986) The Geochemistry of iodine - a review. Environ. Geochem. Health, 8(2), 31-5 4.
39. Koutras, D.A.; Matovinovic, J. and Vought, R. (1980) The ecology of iodine. In Endemic goiter and endemic cretinism; (Stanbury, J.B.and Hetzel, B.S. eds.) New York: JohnWiley publ, pp. 185-195.
40. Krajcovicová-Kudlácková, M.; Bucková, K.; Klimes, I. and Seboková, E. (2003) Iodine deficiency in vegetarians and vegans. Ann. Nutr. Metab., 47(5), 183-185.
41. Lentze, M.J. (2001) Vegeterian nutrition and extreme diets in childhood. Monatsschr Kinderheilkd, 149(1), 19-24.
42. McDowell, L.R. (2003) Minerals in animal and human nutrition; Iodine 2nd ed.; Elsevier, p. 305-334.
43. Jongbloed, A.W.; Kemme, P.A.; De Groote, G.; Lippens, M. and Meschy, F. (2002) Bioavailability of major and trace elements; EMFEMA: Brussels, pp. 188.
44. Anke, M.; Groppel, B. and Scholz, E. (1993) Iodine in the food chain. Proc. Trace Elements in Man and Animals (TEMA 8), pp. 1049-1053.
45. Underwood, E.J. and Suttle, N.F. (2001) Iodine. in The mineral nutrition of livestock; 3rd ed. CAB International: Wallington, UK, pp. 343-374.
46. Pandav, C.S. and Rao, A.R. (1997) Iodine Deficiency Disorders in Livestock. Ecology and Economics; Oxford University Press publ, p. 288.
47. Pittman, J.A.Jr.C.S. and Pittman, J.C. (1997) Iodine deficiency and animal production. In Iodine deficiency disorders in Livestock. (Pandav, C.S. and Rao, A.R. Eds.) Oxford University Press publ: Dehli, pp. 147-160.
48. Jahreis, G.; Haussmann, W.; Kiessling, G.; Franke, K. and Leiterer, M. (2001) Bioavaibility of iodine from normal diets rich in dairy products - results of balance studies in women. Exp. Clin. Endocrinol. Diabetes, 109(3), 163-167.
49. Rasmussen, L.B.; Ovesen, L.; Bülow, I.; Jørgensen, T.; Knudsen, N.; Laurberg, P. and Perrild, H. (2002) Dietary iodine intake and urinary iodine excretion in a Danish population: effect of geography, supplements and food choice. Br. J. Nutr., 87(1), 61-69.
50. Wiersinga, W.M.; Podoba, J.; Srbecky, M.; van Vessem, M.; van Beeren, H.C.; Platvoet-Ter and Schiphorst, M.C. (2001) A survey of iodine intake and thyroid volume in Dutch schoolchildren: reference values in an iodine-sufficient area and the effect of puberty. Eur. J. Endocrinol. Jun., 144(6), 595-603.
51. Als, C.; Haldimann, M.; Burgi, E.; Donati, F.; Gerber, H. and Zimmerli, B. (2003) Swiss pilot study of individual seasonal fluctuations of urinary iodine concentration over two years: is age-dependency linked to the major source of dietary iodine? Eur. J. Clin. Nutr., 57(5), 636-646.
52. Trumbo, P.; Yates, A.A.; Schlicker, S. and Poos, M. (2001) Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Am. Diet Assoc., 101(3), 294-301
53. Dunn, J.T. (1997) Adverse effects of iodine deficiency and its eradication by iodine supplementation. in Contemporary endocrinology: diseases of the thyroid; (Braverman LE, Ed.) Totowa, NJ: Humana Press, Inc, pp. 349-360.
54. Delange, F. (1994) The disorders induced by iodine deficiency. Thyroid, 4(1), 107-128.
55. Dunn, J.T. (1996) Seven deadly sins in confronting endemic iodine deficiency, and how to avoid them. J. Clin. Endocrinol. Metab., 81(4), 1332-1335.
56. WHO, UNICEF, and ICCIDD. (1994) Indicators for assessing Iodine Deficiency Disorders and their control through salt iodization; Geneva: WHO publ. WHO/NUT/94.6. pp. 1-55.
57. WHO, UNICEF, and ICCIDD. (2001) Assessment of the Iodine Deficiency Disorders and monitoring their elimination; Geneva: WHO publ. WHO/NHD/01.1. pp. 1-107
58. Gaitan E. Goitrogens in the etiology of endemic goiter. (1980) in Endemic goiter and endemic cretinism. Iodine nutrition in health and disease; (Stanbury, J.B. and Hetzel, B.S. Eds.) New York: JohnWiley publ. pp. 219-236.
59. Gaitan E. (1989) Environmental goitrogenesis. Boca Raton: CRC Press publ. pp. 1-250.
60. Dumont, J.E.; Ermans, A.M.; Maenhaut, G.; Coppée, F. and Stanbury, J.B. (1995) Large goiter as a maladaptation to iodine deficiency. Clin. Endocrinol. (Oxf)., 43(1), 1-10.
61. Ermans, A.M.; Dumont, J.E. and Bastenie, P.A. (1963) Thyroid function in a goitrous endemic. II. Nonhormonal iodine escape from the goitrous gland. J. Clin. Endocrinol. Metab., 23, 550-560.
62. Delange, F. (2002) Iodine deficiency in Europe and its consequences: an update. Eur. J. Nucl. Med. Mol. Imaging, 29(Suppl 2), S404-16.
63. Vitti, P.; Delange, F.; Pinchera, A.; Zimmermann, M. and Dunn, J.T. (2003) Europe is iodine deficient. Lancet, 361(9364), 1226.
64. Levander, O.A. and Whanger, P.D. (1996) Deliberations and evaluations of the approaches, endpoints and paradigms for selenium and iodine dietary recommendations. J. Nutr., 126(9 Suppl), 2427S-34S.
65. DeLong, R. (1987) Neurological involvement in Iodine Deficiency Disorders. in The prevention and control of Iodine Deficiency Disorders; (Hetzel, B.S.; Dunn, J.T. and Stanbury, J.B. Eds.) Amsterdam: Elsevier publ. pp. 49-63.
66. Delange F. (1974) Endemic goitre and thyroid function in Central Africa. Monographs in Pediatrics. Basel: S. Karger publ. pp 1-171.
67. Pharoah, P.O.; Buttfield, I.H. and Hetzel, B.S. (1971) Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet, 1(7694), 308-310.
68. Vulsma, T.; Gons, M.H. and de Vijlder, J.J. (1989) Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N. Engl. J. Med., 321(1), 13-16.
69. Contempre, B.; Jauniaux, E.; Calvo, R.; Jurkovic, D.; Campbell, S. and Morreale de Escobar, G. (1993) Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J. Clin. Endocrinol. Metab., 77(6), 1719-1722.
70. Choufoer, M.; van Rijn, M. and Querido, (1965) A. Endemic goiter in Western New Guinea. II Clinical picture, incidence and pathogenesis of endemic cretinism. J. Clin. Endocrinol. Metab., 25, 385-402.
71. Thilly, C.H.; Delange, F.; Goldstein-Golaire, J. and Ermans, A-M. (1973) Endemic goiter prevention by iodized oil: a reassessment. J. Clin. Endocrinol. Metab., 36(6):1196-1204.
72. Vanderpas, J.B.; Rivera-Vanderpas, M.T.; Bourdoux, P.; Luvivila, K.; Lagasse, R.; Perlmutter, C.N.; Delange, F.; Lanoie, A.M.; Ermans, A.-M. and Thilly, C.H. (1986) Reversibility of severe hypothyroidism with supplementary iodine in patients with endemic cretinism. N. Engl. J. Med., 315(13), 791-795.
73. McCarrison, R. (1908) Observations on endemic cretinism in the Chitral and Gilgit valleys. Lancet, 2, 1275-1280.
74. Boyages, S.C.; Halpern, J.-P.; Maberly, G.F.; Eastman, C.J.; Chen, J.; Zhen-Hua, W.; Van der Gaag, R.D. and Drexhage, H.A. (1989) Endemic cretinism: possible role for thyroid autoimmunity. Lancet, 2(8662), 529-532.
75. Chiovato, L.; Vitti, P.; Bendinelli, G.; Santini, F.; Fiore, E.; Tonacchera, M.; Mammoli, C.; Capaccioli, A.; Venturi, S.; Pretell, E. and Pinchera, A. (1995) Humoral thyroid autoimmunity is not involved in the pathogenesis of myxedematous endemic cretinism. J. Clin. Endocrinol. Metab., 80(5), 1509-1514.
76. Delange, F. and Ermans, A.M. (1971) Role of a dietary goitrogen in the etiology of endemic goiter on Idjw Island. Am. J. Clin. Nutr., 24(11), 1354-1360.
77. Goyens, P.; Golstein, J.; Nsombola, B.; Vis, H. and Dumont, J.E. (1987) Selenium deficiency as a possible factor in the pathogenesis of myxoedematous endemic cretinism. Acta Endocrinol., 114(4), 497-502.
78. Oliver, J.W. (1976) Interrelationships between athyreotic and manganese-deficient states in rats. Am. J. Vet Res., 37(5), 597-600.
79. Zimmermann, M.B. and Köhrle, J. (2002) The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid, 12(10), 867-878.
80. Vanderpas, J.B.; Contemprè, B.; Duale, N.L.; Goossens, W.; Bebe, N.; Thorpe, R.; Ntambue, K.; Dumont, J.E.; Thilly, C.H. and Diplock, A.T. (1990) Iodine and selenium deficiency associated with cretinism in Zaire. Am. J. Clin. Nutr., 52(6), 1087-1093.
81. Dumont, J.E.; Corvilain, B. and Contemprè, B. (1994) The biochemistry of endemic cretinism: roles of iodine and selenium deficiency and goitrogens. Mol. Cell Endocrinol., 100(1-2), 163-166.
82. Dumont, J.E.; Ermans, A.-M. and Bastenie, P.A. (1963) Thyroidal function in a goiter endemic. IV. Hypothyroidism and endemic cretinism. J. Clin. Endocrinol. Metab., 23, 325-335.
83. Dumont, J.E.; Ermans, A.-M. and Bastenie, P.A. (1963) Thyroidal function in a goiter endemic. V. Mechanism of thyroid failure in the Uele endemic cretins. J. Clin. Endocrinol. Metab. 23, 847-86 0.
84. Bastenie, P.A.; Ermans, A.-M.; Thys, O.; Beckers, C.; van den Schriek, H.G. and de Visscher, M. (1962) Endemic goiter in the Uele region. III. Endemic cretinism. J. Clin. Endocrinol. Metab., 22, 187-94.
85. Dumont, J.E.; Delange, F. and Ermans, A.M. (1969) Endemic cretinism. in Endemic goiter; (Stanbury, J.B., Ed.) Washington DC: Pan American Health Organization, pp. 91-98.
86. Contempre, B.; de Escobar, G.M.; Denef, J.F.; Dumont, J.E. and Many, M.C. (2004) Thiocyanate induces cell necrosis and fibrosis in seleniumand iodine-deficient rat thyroids: a potential experimental model for myxedematous endemic cretinism in Central Africa. Endocrinology, 145(2), 994-1002.
87. Contempre, B.; Dumont, J.E.; Bebe, N.; Thilly, C.H.; Diplock, A.T. and Vanderpas, J. (1991) Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium. J. Clin. Endocrinol. Metab., 73(1), 213-215.
88. Contempre, B.; Le Moine, O.; Dumont, J.E.; Denef, J.-F. and Many, M.C. (1996) Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor β (TGF-β). Mol. Cell Endocrinol., 124(1-2), 7-15.
89. Contempre, B.; Duale, G.L.; Gervy, C.; Alexandre, J.; Vanovervelt, N. and Dumont, J.E. (1996) Hypothyroid patients showing shortened responsiveness to oral iodized oil have paradoxically low serum thyroglobulin and low thyroid reserve. Thyroglobulin/ thyrotropin ratio as a measure of thyroid damage. Eur. J. Endocrinol., 134(3), 342-351.
90. Gaitan, E. and Cooksey, R.C. (1989) General concepts of environmental goitrogenesis. in Environmental goitrogenesis; (Gaitan, E.Ed.) Boca Raton, FL: CRC Press, pp. 3-11.
91. Delange, F. and Cassava (1989) The thyroid. in Environmental goitrogenesis; (Gaitan, E., Ed.) Boca Raton, FL: CRC Press, pp. 173-94.
92. Wollman, S.H. (1962) Inhibition by thiocyanate of accumulation of radioiodine by the thyroid gland. Am. J. Physiol., 203, 517-524.
93. Boyages, S.C.; Halpern, J.P.; Maberly, G.F.; Eastman, C.J.; Chen, J.; Wang, Z.H.; van der Gaag, R.D. and Drexhage, H.A. (1989) Endemic cretinism: possible role for thyroid autoimmunity. Lancet, 2(8662), 529-532.
94. Medeiros-Neto, G.; Tsuboi, K. and Lima, N. (1990) Thyroid auto-immunity and endemic cretinism. Lancet, 335(8681), 111.
95. DeLong, G.R.; Leslie, P.W.; Wang, S.H.; Jiang, X.M.; Zhang, M.L.; Rakeman, M.; Jiang, J.Y.; Ma, T. and Cao, X.Y. (1997) Effect on infant mortality of iodination of irrigation water in a severely iodine-deficient area of China. Lancet, 350(9080), 771-773.
96. Hetzel, B.S. (2000) Iodine and neuropsychological development. J. Nutr., 130(2S Suppl), 493S-495S.
97. Bleichrodt, N.; Shrestha, R.M.; West, C.E.; Hautvast, J.G.; van de Vijver, F.J. and Born, M.P. (1996) The benefits of adequate iodine intake. Nutr. Rev., 54(4 Pt 2): S72-S778.
98. Tiwari, B.D.; Godbole, M.M.; Chattopadhyay, N.; Mandal, A. and Mithal, A. (1996) Learning disabilities and poor motivation to achieve due to prolonged iodine deficiency. Am. J. Clin. Nutr., 63(5), 782-786.
99. Zanzonico, P.B. and Becker, D.V. (2000) Effects of time of administration and dietary iodine levels on potassium iodide (KI) blockade of thyroid irradiation by 131I from radioactive fallout. Health Phys., 78(6), 660-667.
100. Nauman, J. and Wolff, J. (1993) Iodide prophylaxis in Poland after the Chernobyl reactor accident: benefits and risks. Am. J. Med., 94(5), 524-532.
101. Davidsson, L. (1999) Are vegetarians an 'at risk group' for iodine deficiency? Br. J. Nutr., 81(1), 3-4.
102. Remer, T.; Neubert, A. and Manz, F. (1999) Increased risk of iodine deficiency with vegetarian nutrition. Br. J. Nutr., 81(1), 45-49.
103. Thomson, C.D.; Woodruffe, S.; Colls, A. and Doyle, T.D. (2000) Urinary iodine and thyroid status of New Zealand residents. in Trace Elements in Man and Animals; (Roussel, A.M.; Anderson, R.A. and Favier, A. Eds.) New York: Kluwer Academic Press, Vol. 10, pp. 343-344.
104. Hollowell, J.G.; Staehling, N.W.; Hannon, W.H.; Flanders, D.W.; Gunter, E.W.; Maberly, G.F.; Braverman, L.E.; Pino, S.; Miller, D.T.; Garbe, P.L.; DeLozier, D.M. and Jackson, R.J. (1998) Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994). J. Clin. Endocrinol. Metab., 83(10), 3401-3408.
105. Sigui, A.C. and Endemic Goiter in Guatemala. (1986) in Towards the eradication of endemic goiter, cretinism, and iodine dificienty; (Dunn, J.T.; Pretell, E.A.; Daza, C.H. and Viteri, F.E. Eds.) Washington, DC: Pan American Health Organization, pp. 300-302.
106. Braverman, L.E. (1994) Iodine and the thyroid: 33 years of study. Thyroid, 4(3), 351-356.
107. Stanbury, J.B.; Ermans, A.E.; Bourdoux, P.; Todd, C.; Oken, E.; Tonglet, R.; Vidor, G.; Braverman, L.E. and Medeiros-Neto, G. (1998) Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid, 8(1), 83-100.
108. Dremier, S.; Coppée, F.; Delange, F.; Vassart, G.; Dumont, J.E. and Van Sande, J. (1996) Thyroid autonomy: mechanism and clinical effects. J. Clin. Endocrinol. Metab., 81(12), 4187-4193.
109. Todd, C.H.; Allain, T.; Gomo, Z.A.R.; Hasler, J.A.; Ndiweni, M. and Oken, E. (1995) Increase in thyrotoxicosis associated with iodine supplements in Zimbabwe. Lancet, 346(8989), 1563-1564.
110. Delange, F. (1998) Risks and benefits of iodine supplementation. Lancet, 351(9107), 923-924.
111. Dunn, J.T.; Semigran, M.J. and Delange, F. (1998) The prevention and management of iodine-induced hyperthyroidism and its cardiac features. Thyroid, 8(1), 101-106.
112. Braverman, L.E. (1998) Adequate iodine intake - the good far outweights the bad. Eur. J. Endocrinol., 139(1), 14-15.
113. Harach, H.R.; Escalante, D.A.; Onativia, A.; Outes, J.L.; Day, E.S. and Williams, E.D. (1985) Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis. Acta Endocrinol. (Copenh), 108(1), 55-60.
114. Delange, F.; Ermans, A.M.; Vis, H.L. and Stanbury, J.B. (1972) Endemic cretinism in Idjwi Island (Kivu Lake, Republic of the Congo). J. Clin. Endocrinol. Metab., 34(6), 1059-1066.
115. Melot, G.J.; Jeanmart-Michez, L.; Dumont, J.; Ermans, A.M. and Bastenie, P. (1962) Les aspects radiologiques du crétinisme endémique. J. Belg. Radiol., 45, 385-403.
116. Thilly, C.H.; Vanderpas, J.; Bourdoux, P.; Lagasse, R.; Lody, D.; Smitz, J. and Ermans, A.M. (1983) Prevention of myxedematous cretinism with iodized oil during pregnancy. in Current problems in thyroid research; (Ui, N.; Torizuka, K.; Nagataki, S. and Miyai, K. Eds.) Amsterdam: Excerpta Medica publ, pp. 386-389.
117. Harach, H.R.; Franssila, K.O. and Wasenius, V.-M. (1985) Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer, 56(3), 531-538.
118. Burk, R.F. and Levander, O.A. (1999) Selenium. in Nutrition in Health and Disease; (Shils, M.; Olson, J.A.; Shike, M. and Ross, A.C. Eds.) 9th ed. Baltimore: Williams & Wilkins, pp. 265-276.
119. Rayman, M.P. and Clark, L.C. (2000) Selenium in cancer prevention. in Trace elements in man and animals; (Roussel, A.M. Ed.) 10th ed. New York: Plenum Press, pp. 575-580.
120. Combs, G.F. Jr and Gray, W.P. (1998) Chemopreventive agents: selenium. Pharmacol. Ther., 79(3), 179-192.
121. Dickson, R.C. and Tomlinson, R.H. (1967) Selenium in blood and human tissues. Clin. Chim. Acta, 16(2), 311-321.
122. Oster, O.; Schmiedel, G. and Prellwitz, W. (1988) The organ distribution of selenium in German adults. Biol. Trace Elem. Res., 15, 23-45.
123. Oster, O. and Prellwitz, W. (1990) The renal excretion of selenium. Biol. Trace Elem. Res., 24(2), 119-46.
124. Aaseth, J.; Frey, H.; Glattre, E.; Norheim, G.; Ringstad, J. and Thomassen, Y. (1990) Selenium concentrations in the human thyroid gland. Biol. Trace Elem. Res., 24(2), 147-152.
125. Tiran, B.; Karpf, E. and Tiran, A. (1995) Age dependency of selenium and cadmium content in human liver, kidney, and thyroid. Arch. Environ. Health, 50(3), 242-246.
126. Drasch, G.; Wanghofer, E.; Roider, G. and Strobach, S. (1996) Correlation of mercury and selenium in the human kidney. J. Trace Elem. Med. Biol., 10(4), 251-4.
127. Rayman, M.P. (2000) The importance of selenium to human health. Lancet, 356(9225), 233-2341.
128. Holben, D.H. and Smith, A.M. (1999) The diverse role of selenium within selenoproteins: a review. J. Am. Diet Assoc., 99(7), 836-843.
129. Ursini, F.; Heim, S.; Kiess, M.; Maiorino, M.; Roveri, A.; Wissing, J. and L. (1999) Dual function of the selenoprotein PHGPx during sperm maturation. Science, 285(5432), 1393-1396.
130. Mustacich, D. and Powis, G. (2000) Thioredoxin reductase. Biochem. J., 346 Pt 1, 1-8.
131. Food and Nutrition Board, Institute of Medicine. (2000) Selenium. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids: Washington D.C.:NationalAcademyPress, pp.284-324.
132. Roy, M.; Kiremidjian-Schumacher, L.; Wishe, H.I.; Cohen, M.W. and Stotzky, G. (1994) Supplementation with selenium and human immune cell functions. I. Effect on lymphocyte proliferation and interleukin 2 receptor expression. Biol. Trace Elem. Res., 41(1-2), 103-114.
133. Kiremidjian-Schumacher, L.; Roy, M.; Wishe, H.I.; Cohen, M.W. and Stotzky, G. (1994) Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells. Biol. Trace Elem. Res., 41(1-2), 115-127.
134. Garland, M.; Morris, J.S.; Stampfer, M.J.; Colditz, G.A.; Spate, V.L.; Baskett, C.K.; Rosner, B.; Speizer, F.E.; Willett, W.C. and Hunter, D.J. (1995) Prospective study of toenail selenium levels and cancer among women. J. Natl. Cancer Inst., 87(7), 497-505.
135. Yu, M.W.; Horng, I.S.; Hsu, K.H.; Chiang, Y.C.; Liaw, Y.F. and Chen, C.J. (1999) Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am. J. Epidemiol., 150(4), 367-374.
136. Knekt, P.; Marniemi, J.; Teppo, L.; Heliovaara, M. and Aromaa, A. (1998) Is low selenium status a risk factor for lung cancer? Am. J. Epidemiol., 148(10), 975-982.
137. Yoshizawa, K.; Willett, W.C.; Morris, S.J.; Stampfer, M.J.; Spiegelman, D.; Rimm, E.B. and Giovannucci, E. (1998) Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J. Natl. Cancer Inst., 90(16), 1219-1224.
138. Köhrle, J. (1999) Local activation and inactivation of thyroid hormones: the deiodinase family. Mol. Cell Endocrinol., 151(1-2), 103-119.
139. Leonard, J.L. and Köhrle, J. (2000) Intracellular pathways of thyroid hormone metabolism. in Werner and Ingbar's the thyroid-a fundamental and clinical text; (Braverman, L.E.; Utiger, R.D. Eds.) Philadelphia: J. B. Lippincott Company, pp. 136-73.
140. Köhrle, J. (2002) Iodothyronine deiodinases. Methods Enzymol, 347, 125-167.
141. Toyoda, N.; Kaptein, E.; Berry, M.J.; Harney, J.W.; Larsen, P.R. and Visser, T.J. (1997) Structure-activity relationships for thyroid hormone deiodination by mammalian type I iodothyronine deiodinases. Endocrinology, 138(1), 213-219.
142. Baur, A.; Buchfelder, M. and Köhrle J. (2002) Expression of 5′-deiodinase enzymes in normal pituitaries and in various human pituitary adenomas. Eur. J. Endocrinol., 147(2), 263-268.
143. Leonard, J.L.; Ekenbarger, D.M.; Frank, S.J.; Farwell, A.P. and Köhrle, J. (1991) Localization of type I iodothyronine 5′deiodinase to the basolateral plasma membrane of rat kidney and LLC-PK1 renal cortical cells. J. Biol. Chem., 66(17), 11262-11269.
144. Santini, F.; Chiovato, L.; Lapi, P.; Lupetti, M.; Dolfi, A.; Bianchi, F.; Bernardini, N.; Bendinelli, G.; Mammoli, C.; Vitti, P.; Chopra, I.J. and Pinchera, A. (1995) The location and the regulation of the type Iiodothyronine 5′-monodeiodinase (type I-MD) in the rat thyroid: studies using a specific anti-type I-MD antibody. Mol. Cell Endocrinol., 110(1-2), 195-203.
145. Prabakaran, D.; Ahima, R.S.; Harney, J.W.; Berry, M.L.; Larsen, P.R. and Arvan, P. (1999) Polarized targeting of epithelial cell proteins in thyrocytes and MDCK cells. J. Cell Sci., 112(Pt 8), 1247-1256.
146. Baur, A.; Bauer, K.; Jarry, H. and Köhrle, J. (1997) 3,5-Di-iodo-l-thyronine stimulates type I 5′-deiodinase activity in rat anterior pituitaries in vivo and in reaggregate cultures and GH3 cells in vitro. Endocrinology, 138(8), 3242-3248.
147. Baur, A. and Köhrle, J. (1999) Type I 5'-deiodinase is stimulated by iodothyronines and involved in thyroid hormone metabolism in human somatomammotroph GX cells. Eur. J. Endocrinol., 140(4), 367-370.
148. O'Mara, B.; Dittrich, W.; Lauterio, T.J. and St Germain, D.L. (1994) Pretranslational regulation of type I 5'-deiodinase by thyroid hormones and in fasted and diabetic rats. Endocrinology, 133, 1715-1723.
149. Menjo, M.; Murata, Y.; Fujii, T.; Nimura, Y. and Seo, H. (1993) Effects of thyroid and glucocorticoid hormones on the level of messenger ribonucleic acid for iodothyronine type I 5′-deiodinase in rat primary hepatocyte cultures grown as spheroids. Endocrinology, 133(6), 2984-2990.
150. Maia, A.L.; Harney, J.W. and Larsen, P.R. (1995) Pituitary cells respond to thyroid hormone by discrete, gene-specific pathways. Endocrinology, 136(11), 4842-4849.
151. Ip, C.; Lisk, D.J. and Ganther, H.E. (2000) Chemoprevention with triphenylselenonium chloride in selenium-deficient rats. Anticancer Res., 20(6B), 4179-4182.
152. Baur, A.; Bauer, K.; Jarry, H. and Köhrle, J. (2000) Effects of proinflammatory cytokines on anterior pituitary 5′-deiodinase type I and type II. J. Endocrinol., 167(3), 505-515.
153. Köhrle, J. (1990) Thyrotropin (TSH) action on thyroid hormone deiodination and secretion: one aspect of thyrotropin regulation of thyroid cell biology. Hormone Metab. Res., 23(Suppl), 18-28.
154. Villette, S.; Bermano, G.; Arthur, J.R. and Hesketh, J.E. (1998) Thyroid stimulating hormone and selenium supply interact to regulate selenoenzyme gene expression in thyroid cells (FRTL-5) in culture. FEBS Lett., 438(1-2), 81-84.
155. Beech, S.G.; Walker, S.W.; Arthur, J.R.; Lee, D. and Beckett, G.J. (1995) Differential control of type-I iodothyronine deiodinase expression by the activation of the cyclic AMP and phosphoinositol signalling pathways in cultured human thyrocytes. J. Mol. Endocrinol., 14(2), 171-177.
156. DePalo, D.; Kinlaw, W.B.; Zhao, C.; Engelberg-Kulka, H. and St Germain, D.L. (1994) Effect of selenium deficiency on type I 5′-deiodinase. J. Biol. Chem., 269(23), 16223-16228.
157. Meinhold, H.; Campos-Barros, A.; Walzog, B.; Köhler, R.; Müller, F. and Behne, D. (1993) Effects of selenium and iodine deficiency on type I, type II, and type III iodothyronine deiodinases and circulating hormone levels in the rat. Exp. Clin. Endocrinol., 101(2), 87-93.
158. Safran, M.; Farwell, A.P.; Rokos, H. and Leonard, J.L. (1993) Structural requirements of iodothyronines for the rapid inactivation and internalization of type II iodothyronine 5′-deiodinase in glial cells. J. Biol. Chem., 268(19), 14224-14229.
159. Burmeister, L.A.; Pachucki, J. and St Germain, D.L. (1997) Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology, 138(12), 5231-5237.
160. du Mont, W.W.; Mugesh, G.; Wismach, C. and Jones, P.G. (2001) Reactions of organoselenenyl iodides with thiouracil drugs: an enzyme mimetic study on the inhibition of iodothyronine deiodinase. Angew. Chem. Int. Ed. Engl., 40(13), 2486-2489.
161. Mugesh, G.; du Mont, W.W.; Wismach, C. and Jones, P.G. (2002) Biomimetic studies on iodothyronine deiodinase intermediates: modeling the reduction of selenenyl iodide by thiols. Chem. Biol. Chem., 3(5), 440-447.
162. Roy, G.; Nethaji, M. and Mugesh, G. (2004) Biomimetic studies on antithyroid drugs and thyroid hormone synthesis. J. Am. Chem. Soc., 126(9), 2712-2713.
163. Hennemann, G. and Visser, T.J. (1997) Thyroid hormone synthesis, plasma membrane transport and metabolism. in Handbook of Experimental Pharmacology, Pharmacotherapeutics of the Thyroid Gland; (Weetman, A.P.; Grossman, A. Eds.). Springer, Berlin, Vol. 128, pp. 75-117.
164. Leonard, J.L. and Köhrle, J. (2000) Intracellular pathways of iodothyronine metabolism. in The Thyroid; (Braverman, L.E.; Utiger, R.D. Eds.) 8th ed. Lippincott-Raven: Philadelphia, pp. 136-173.
165. St.Germain, D.L. and Galton, V.A. (1997) The deiodinase family of
166. Bianco, A.C.; Salvatore, D.; Gereben, B.; Berry, M.J. and Larsen, P.R. (2002) Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev., 23(1), 38-89.
167. Diano, S.; Naftolin, F.; Goglia, F.; Csernus, V. and Horvath, T.L. (1998) Monosynaptic pathway between the arcuate nucleus expressing glial type II iodothyronine 5′-deiodinase mRNA and the median eminence- projective TRH cells of the rat paraventricular nucleus. J. Neuroendocrinol., 10(10), 731-742.
168. Curcio, C.; Baqui, M.M.; Salvatore, D.; Rihn, B.H.; Mohr, S.; Harney, J.W.; Larsen, P.R. and Bianco, A.C. (2001) The human type 2 iodothyronine deiodinase is a selenoprotein highly expressed in a mesothelioma cell line. J. Biol. Chem., 276(32), 30183-30187.
169. Leonard, J.L. (1988) Dibutyryl cAMP induction of type II 5′deiodinase activity in rat brain astrocytes in culture. Biochem. Biophys. Res. Commun., 151(3), 1164-1172.
170. Safran, M.; Farwell, A.P. and Leonard, J.L. (1996) Catalytic activity of type II iodothyronine 5'-deiodinase polypeptide is dependent upon a cyclic AMP activation factor. J. Biol. Chem., 271(27), 16369-16374.
171. Farwell, A.P. and Leonard, J.L. (1989) Identification of a 27-kDa protein with the properties of type II iodothyronine 5′-deiodinase in dibutyryl cyclic AMP-stimulated glial cells. J. Biol. Chem., 264(34), 20561-20567.
172. Campos-Barros, A.; Musa, A.; Flechner, A.; Hessenius, C.; Gaio, U.; Meinold, H. and Baumgartner, A. (1997) Evidence for circadian variations of thyroid hormone concentrations and type II 5′-iodothyronine deiodinase activity in the rat central nervous system. J. Neurochem., 68(2), 795-803.
173. Baumgartner, A.; Hiedra, L.; Pinna, G.; Eravci, M.; Prengel, H. and Meinhold, H. (1998) Rat brain type II 5′-deiodinase activity is extremely sensitive to stress. J. Neurochem., 71(2), 817-826.
174. Campos-Barros, A.; Hoell, T.; Musa, A.; Sampaolo, S.; Stoltenburg, G.; Pinna, G.; Eravci, M.; Meinhold, H. and Baumgartner, A. (1996) Phenolic and tyrosyl ring deiodination and thyroid hormone concentrations in the human central nervous system. J. Clin. Endocrinol. Metab., 81(6), 2179-2185.
175. Baumgartner, A.; Pinna, G.; Hiedra, L.; Gaio, U.; Hessenius, C.; Campos-Barros, A.; Eravci, M.; Prengel, H.; Thoma, R. and Meinhold, H. (1997) Effects of lithium and carbamazepine on thyroid hormone metabolism in rat brain. Neuropsychopharmacology, 16(1), 25-41.
176. Mitchell, J.H.; Nicol, F.; Beckett, G.J. and Arthur, J.R. (1997) Selenium and iodine deficiencies: effects on brain and brown adipose tissue selenoenzyme activity and expression. J. Endocrinol., 155(2), 255-263.
177. Köhrle, J. (2000) Thyroid hormone metabolism and action in the brain and pituitary. Acta Med. Aust., 27(1), 1-7.
178. Farwell, A.P.; Dubord-Tomasetti, S.A.; Pietrzykowski, A.Z.; Stachelek, S.J. and Leonard, J.L. (2005) Regulation of cerebellar neuronal migration and neurite outgrowth by thyroxine and 3,3′,5′-triiodothyronine. Brain Res. Dev. Brain Res., 154(1), 121-135.
179. Koopdonk-Kool, J.M.; De Vijlder, J.J.; Veenboer, G.J.; Ris Stalpers, C.; Kok, J.H.; Vulsma, T.; Boer, K. and Visser, T.J. (1996) Type II and type III deiodinase activity in human placenta as a function of gestational age. J. Clin. Endocrinol. Metab., 81(6), 2154-2158.
180. Köhrle, J. (2003) Fetal thyroid hormone provision: the role of placental transport and deiodination of thyroid hormones. in The thyroid and brain; (Morreale de Escobar, G.; De Vijlder, J.J.M.; Butz, S.; Hostalek, U. Eds.) Stuttgart, Schattauer: Germany pp. 67-81.
181. Santini, F.; Chiovato, L.; Ghirri, P.; Lapi, P.; Mammoli, C.; Montanelli, L.; Scartabelli, G.; Ceccarini, G.; Coccoli, L.; Chopra, I.J.; Boldrini, A. and Pinchera, A. (1999) Serum iodothyronines in the human fetus and the newborn: evidence for an important role of placenta in fetal thyroid hormone homeostasis. J. Clin. Endocrinol. Metab., 84(2), 493-498.
182. Krysin, E.; Brzezinska-Slebodinska, E. and Slebodzinski, A.B. (1997) Divergent deiodination of thyroid hormones in the separated parts of fetal and maternal placenta in pigs. J. Endocrinol., 155(2), 295-303.
183. Pavelka, S.; Kopecky, P.; Bendlova, B.; Stolba, P.; Vitkova, I.; Vobruba, V.; Plavka, R.; Houstek, J. and Kopecky, J. (1997) Tissue metabolism and plasma levels of thyroid hormones in critically ill very premature infants. Pediatr. Res., 42(6), 812-818.
184. Santini, F.; Vitti, P.; Chiovato, L.; Ceccarini, G.; Macchia, M.; Montanelli, L.; Gatti, G.; Rosellini, V.; Mammoli, C.; Martino, E.; Chopra, I.J.; Safer, J.D.; Braverman, L.E. and Pinchera, (2003) A. Role for inner ring deiodination preventing transcutaneous passage of thyroxine. J. Clin. Endocrinol. Metab., 88(6), 2825-2830.
185. Galton, V.A.; Martinez, E.; Hernandez, A.; St Germain, E.A.; Bates, J.M. and St Germain, D.L. (1999) Pregnant rat uterus expresses high levels of the type 3 iodothyronine deiodinase. J. Clin. Invest., 103(7), 979-987.
186. Huang, S.A.; Dorfman, D.M.; Genest, D.R.; Salvatore, D. and Larsen, P.R. (2003) Type 3 Iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J. Clin. Endocrinol. Metab., 88(3), 1384-1388.
187. St Germain, D.L. (1994) Biochemical Study of type III iodothyronine deiodinase. in Thyroid Hormone Metabolism: Molecular Biology and Alternate Pathways; (Wu, S.Y.; Visser, T.J. Eds.) CRC Press: Baco Raton, pp. 45-66.
188. Chanoine, J.P.; Alex, S.; Stone, S.; Fang, S.L.; Veronikis, I.; Leonard, J.L. and Braverman, L.E. (1993) Placental 5-deiodinase activity and fetal thyroid hormone economy are unaffected by selenium deficiency in the rat. Pediatr. Res., 34(3), 288-292.
189. Ramaugé, M.; Pallud, S.; Esfandari, A.; Gavaret, J.M.; Lennon, A.M.; Pierre, M. and Courtin, F. (1996) Evidence that type III iodothyronine deiodinase in rat astrocyte is a selenoprotein. Endocrinology, 137(7), 3021-3025.
190. Pallud, S.; Ramaugé, M.; Gavaret, J.M.; Lennon, A.M.; Munsch, N.; St Germain, D.L.; Pierre, M. and Courtin, F. (1999) Regulation of type 3 iodothyronine deiodinase expression in cultured rat astrocytes: role of the Erk cascade. Endocrinology, 140(6), 2917-2923.
191. Hernàndez, A.; St Germain, D.L. and Obregon, M.J. (1998) Transcriptional activation of type III inner ring deiodinase by growth factors in cultured rat brown adipocytes. Endocrinology, 139(2), 634-639.
192. Hernàndez, A. and St Germain, D.L. (2003) Activity and response to serum of the mammalian thyroid hormone deiodinase 3 gene promoter: identification of a conserved enhancer. Mol. Cell Endocrinol., 206(1-2), 23-32.
193. Huang, S.A.; Tu, H.M.; Harney, J.W.; Venihaki, M.; Butte, A.J.; Kozakewich, H.P.; Fishman, S.J. and Larsen, P.R. (2000) Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N. Engl. J. Med., 343(3), 185-189.
194. Huang, S.A.; Fish, S.A.; Dorfman, D.M.; Salvatore, D.; Kozakewich, H.P.; Mandel, S.J. and Larsen, P.R. (2002) A 21-year old woman with consumptive hypothyroidism due to a vascular tumor expressing type 3 iodothyronine deiodinase. J. Clin. Endocrinol. Metab., 87(10), 4457-4461.
195. Peeters, R.P.; Wouters, P.; Kaptein, E.; van Toor, H.; Viser, T.J. and Van den Berghe, G. (2002) Program of the 84th Annual Meeting of the Endocrine Society, San Francisco, Abstract OR9-2.
196. Chang, J.C.; Chang, J.C.; Gutenmann, W.H.; Reid, C.M. and Lisk, D.J. (1995) Selenium content of brazil nuts from two geographic locations in Brazil. Chemosphere, 30(4), 801-802.
197. Schrauzer, G.N. (2000) Selenomethionine: a review of its nutritional significance, metabolism and toxicity. J. Nutr., 130(7), 1653-1656.
198. Foster, L.H. and Sumar, S. (1997) Selenium in health and disease: a review. Crit. Rev. Food Sci. Nutr., 37(3), 211-228.
199. Beck, M.A.; Esworthy, R.S.; Ho, Y.S. and Chu, F.F. (1998) Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J., 12(12), 1143-1149.
200. Levander OA. (2000) Coxsackievirus as a model of viral evolution driven by dietary oxidative stress. Nutr. Rev., 58(2 Pt 2), S17-S24.
201. Baum, M.K.; Miguez-Burbano, M.J.; Campa, A.; Shor-Posner, G. (2000) Selenium and interleukins in persons infected with human immunodeficiency virus type 1. J. Infect. Dis., 182 (Suppl 1), S69-S73.
202. Demelash, A.; Karlsson, J.O.; Nilsson, M. and Björkman, U. (2004) Selenium has a protective role in caspase-3-dependent apoptosis induced by H2O2 in primary cultured pig thyrocytes. Eur. J. Endocrinol., 150(6), 841-849.
203. Gartner, R.; Gasnier, B.C.; Dietrich, J.W.; Krebs, B. and Angstwurm, M.W. (2002) Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J. Clin. Endocrinol. Metab., 87(4), 1687-1691.
204. Duntas, L.H.; Mantzou, E. and Koutras, D.A. (2003) Effects of a six month treatment with selenomethionine in patients with auto-immune thyroiditis. Eur. J. Endocrinol., 148(4), 389-393.
205. Vulsma, T.; Gons, M.H. and de Vijlder, J.J. (1989) Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N. Engl. J. Med., 321(1), 13-16.
206. Contempre, B.; Jauniaux, E.; Calvo, R.; Jurkovic, D.; Campbell, S. and Morreale de Escobar, G. (1993) Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J. Clin. Endocrinol. Metab., 77(6), 1719-1722.
207. Contempre, B.; Dumont, J.E., Bebe, N., Thilly, C.H., Diplock, A.T.; Vanderpas, J. (1991) Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium. J. Clin. Endocrinol. Metab., 73(1), 213-215.
208. Contempre, B.; Duale, N.L.; Dumont, J.E.; Ngo, B.; Diplock, A.T. and Vanderpas, J. (1992) Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clin. Endocrinol. (Oxf)., 36(6), 579-583.
209. Contempre, B.; Denef, J.F.; Dumont, J.E. and Many, M.C. (1993) Selenium deficiency aggravates the necrotizing effects of a high iodide dose in iodine deficient rats. Endocrinology, 132(4), 1866-1868.
210. Mahmoud, I.; Colin, I.; Many, M.C. and Denef, J.F. (1986) Direct toxic effect of iodide in excess on iodine-deficient thyroid glands: epithelial necrosis and inflammation associated with lipofuscin accumulation. Exp. Mol. Pathol., 44(3), 259-271.
211. Many, M.C.; Denef, J.F.; Hamudi, S. and Haumont, S. (1986) Increased follicular heterogeneity in experimental colloid goiter produced by refeeding iodine excess after thyroid hyperplasia. Endocrinology, 118(2), 637-644.
212. Rognoni, J.B.; Penel, C.; Golstein, J.; Galand, P. and Dumont, J.E. (1987) Cell kinetics of thyroid epithelial cells during hyperplastic goitre involution. J. Endocrinol., 114(3), 483-490.
213. van den Hove-Vandenbroucke, M.F.; Santisteban, P.; Couvreur, M.; Obregon, M.J. and Lamas, L. (1982) Involution of rat iodoprive hyperplastic goiter: effect of iodide administration on thyroid function and lysosomal properties. Endocrinology, 110(5), 1812-1818.
214. Many, M.C.; Mestdagh, C.; van den Hove, M.F. and Denef, J.F. (1992) In vitro study of acute toxic effects of high iodide doses in human thyroid follicles. Endocrinology, 131(2), 621-630.
215. Contempre, B.; Dumont, J.E.; Denef, J.F. and Many, M.C. (1995) Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism. Eur. J. Endocrinol., 133(1), 99-109.
216. Contempre, B.; de Escobar, G.M.; Denef, J.F.; Dumont, J.E. and Many, M.C. (2004) Thiocyanate induces cell necrosis and fibrosis in seleniumand iodine-deficient rat thyroids: a potential experimental model for myxedematous endemic cretinism in Central Africa. Endocrinology, 145(2), 994-1002.
217. Contempre, B.; Le Moine, O.; Dumont, J.E.; Denef, J.F. and Many, M.C. (1996) Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor β (TGF-β). Mol. Cell Endocrinol., 124(1-2), 7-15.
218. Taton, M.; Lamy, F.; Roger, P.P. and Dumont, J.E. (1993) General inhibition by transforming growth factor β 1 of thyrotropin and cAMP responses in human thyroid cells in primary culture. Mol. Cell Endocrinol., 95(1-2), 13-21.
219. Contempre, B.; Duale, N.L.; Dumont, J.E., Ngo, B.; Diplock, A.T. and Vanderpas, J. (1992) Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clin. Endocrinol. (Oxf)., 36(6), 579-583.
220. Aaseth, J.; Frey, H.; Glattre, E.; Norheim, G., Ringstad, J. and Thomassen, Y. (1990) Selenium concentrations in the human thyroid gland. Biol. Trace Elem. Res., 24(2), 147-152.
221. Glattre, E.; Thomassen, Y.; Thoresen, S.O., Haldorsen, T.; Lund-Larsen, P.G.; Theodorsen, L. and Aaseth, J. (1989) Prediagnostic serum selenium in a case-control study of thyroid cancer. Int. J. Epidemiol., 18(1), 45-49.
222. Aaseth, J. and Glattre, E. (1996) Proc Sixth International Thyroid Symposium; Graz: Austria, pp. 180-184.
223. Derumeaux, H.; Valeix, P.; Castetbon, K., Bensimon, M.; Boutron-Ruault, M.C.; Arnaud, J. and Hercberg, S. (2003) Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. Eur. J. Endocrinol., 148(3), 309-315.
224. Vrca, V.B.; Skreb, F.; Cepelak, I.; Romic, Z. and Mayer, L. (2004) Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium. Clin. Chim. Acta., 341(1-2), 55-63.
225. Negro, R.; Greco, G.; Mangieri, T.; Pezzarossa, A.; Dazzi, D. and Hassan H. (2007) The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J. Clin. Endocrinol. Metab., 92(4), 1263-1268.
226. Karanikas, G.; Schuets, M.; Kontur, S.; Duan, H.; Kommata, S.; Schoen, R.; Antoni, A.; Kletter, K.; Dudczak, R. and Willheim, M. (2008) No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid, 18(1), 7-12.
227. Köhrle, J. (2000) The selenoenzyme family of deiodinase isozymes controls local thyroid hormone availability. Rev. Endocr. Metab. Disord., 1(1-2), 49-58.
228. Hesch, R.D. (1981) The 'low T3-syndrome'. Dtsch. Med. Wochenschr., 106(31-32), 971-2.
229. Berger, M.M.; Lemarchand Beraud, T.; Cavadini, C. and Chiolero, R. (1996) Relations between the selenium status and the low T3 syndrome after major trauma. Intens. Care Med., 22(6), 575-581.
230. Berger, M.M.; Cavadini, C.; Chiolero, R. and Dirren, H. (1996) Copper, selenium, and zinc status and balances after major trauma. J. Trauma, 40(1), 103-109.
231. Nichol, C.; Herdman, J.; Sattar, N.; O'Dwyer, P.J.; St J O'Reilly, D.; Littlejohn, D. and Fell, G. (1998) Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response. Clin. Chem., 44(8 Pt 1), 1764-1766.
232. Chopra, I.J. (1997) Euthyroid sick syndrome. Is it a misnomer? J. Clin. Endocrinol. Metab., 82(2), 329-334.
233. Arem, R.; Wiener, G.J.; Kaplan, S.G.; Kim, H.S.; Reichlin, S. and Kaplan, M.M. (1993) Reduced tissue thyroid hormone levels in fatal illness. Metabolism, 42(9), 1102-1108.
234. Maehira, F.; Luyo, G.A.; Miyagi, I.; Oshiro, M.; Yamane, N.; Kuba, M. and Nakazato Y. (2002) Alterations of serum selenium concentrations in the acute phase of pathological conditions. Clin. Chim. Acta., 316(1-2), 137-146.
235. Terwolbeck, K.; Behne, D.; Meinhold, H.; Menzel, H. and Lombeck, I. (1993) Increased plasma T4-levels in children with low selenium state due to reduced type I iodothyronine 5′-deiodinase activity? J. Trace Elem. Electrolytes Health Dis., 7(1), 53-55.
236. Olivieri, O.; Girelli, D.; Azzini, M.; Stanzial, A.M.; Russo, C.; Ferroni, M. and Corrocher, R. (1995) Low selenium status in the elderly influences thyroid hormones. Clin. Sci., 89(6), 637-642.
237. Chanoine, J.P.; Neve, J., Wu, S.; Vanderpas, J. and Bourdoux, P. (2001) Selenium decreases thyroglobulin concentrations but does not affect the increased thyroxine-to-triiodothyronine ratio in children with congenital hypothyroidism. J. Clin. Endocrinol. Metab., 86(3), 1160-1163.
238. Calomme, M., Vanderpas, J.; Francois, B; Van Caillie-Bertrand, M.; Vanovervelt, N.; Van Hoorebeke, C. and Van den Berghe, D. (1995) Effects of selenium supplementation on thyroid hormone metabolism in phenylketonuria subjects on a phenylalanine restricted diet. Biol. Trace Elem. Res., 47(1-3), 349-353.
239. Kauf, E.; Dawczynski, H.; Jahreis, G.; Janitzky, E. and Winnefeld, K. (1994) Sodium selenite therapy and thyroid-hormone status in cystic fibrosis and congenital hypothyroidism. Biol. Trace Elem. Res., 40(3), 247-253.
240. Kahl, S.; Elsasser, T.H. and Blum, J.W. (2000) Effect of endotoxin challenge on hepatic 5′-deiodinase activity in cattle. Domest. Anim. Endocrinol., 18(1), 133-143.
241. Valverde, C. and Aceves, C. (1989) Circulating thyronine and peripheral monodeiodination in lactating rats. Endocrinology, 124(3), 1340-1344.
242. Calomme, M.R.; Vanderpas, J.B.; Francois, B.; Van Caillie Bertrand, M.; Herchuelz, A.; Vanovervelt, N.; Van Hoorebeke, C.; Van den Berghe, D.A. (1995) Thyroid function parameters during a selenium repletion/depletion study in phenylketonuric subjects. Experientia, 51(12), 1208-1215.
243. Avissar, N.; Ornt, D.B.; Yagil, Y.; Horowitz, S.; Watkins, R.H.; Kerl, E.A.; Takahashi, K.; Palmer, I.S. and Cohen, H.J. (1994) Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am. J. Physiol., 266(2 Pt 1), C367-C375.
244. Makropoulos, W.; Heintz, B. and Stefanidis, I. (1997) Selenium deficiency and thyroid function in acute renal failure. Ren. Failures, 19(1), 129-136.
245. Napolitano, G.; Bonomini, M.; Bomba, G.; Bucci, I.; Todisco, V.; Albertazzi, A. and Monaco, F. (1996) Thyroid function and plasma selenium in chronic uremic patients on hemodialysis treatment. Biol. Trace Elem. Res., 55(3), 221-230.
246. Silverberg, D.S.; Ulan, R.A.; Fawcett, D.M.; Dossetor, J.B.; Grace, M. and Bettcher, K. (1973) Effects of chronic hemodialysis on thyroid function in chronic renal failure. Can. Med. Assoc. J., 109(4), 282-286.
247. Pagliacci, M.C.; Pelicci, G.; Grignani, F.; Giammartino, C.; Fedeli, L.; Carobi, C.; Buoncristiani, U. and Nicoletti, I. (1987) Thyroid function tests in patients undergoing maintenance dialysis: charac terization of the "low-T4 syndrome" in subjects on regular hemodialysis and continuous ambulatory peritoneal dialysis. Nephron, 46(3), 225-230.
248. Köhrle, J.; Braig, F.; Sommer, U.; Reiners, C. and Heidland, A. (1998) Selenund schilddru senhormonstatus bei chronischen dialysepatienten. in Mineralstoffe und spurenelemente; (Köhrle, J. Ed.) Stuttgart, Wissenschaftliche Verlagsgesellschaft mbH: Germany pp..27-31.
249. Kaptein, E.M. (1996) Thyroid hormone metabolism and thyroid disease in chronic renal failure. Endocr. Rev., 17(1), 45-63.
250. Katz, A.I.; Emmanouel, D.S. and Lindheimer, M.D. (1975) Thyroid hormone and the kidney. Nephron, 15(3-5), 223-249.
251. Maisonneuve, P.; Agodoa, L.; Gelert, R.; Stewart, J.H.; Buccianti, G.; Lowenfels, A.B.; Wolfe, R.A.; Jones, E.; Disney, A.P.S.; Briggs, D.; Mc-Credie, M. and Boyle, P. (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet, 354(9173), 93-99.
252. Dumont, J.E.; Corvilain, B. and Contempre, B. (1994) The biochemistry of endemic cretinism: roles of iodine and selenium deficiency and goitrogens. Mol. Cell Endocrinol., 100(1-2): 163-166.
253. Moriarty, P.M.; Picciano, M.F.; Beard, J.L.; Reddy, C.C. (1995) Classical selenium-dependent glutathione peroxidase expression is decreased secondary to iron deficiency in rats. J. Nutr., 125(2), 293-301.
254. Beard, J.L.; Brigham, D.E.; Kelley, S.K. and Green, M.H. (1998) Plasma thyroid hormone kinetics are altered in iron-deficient rats. J. Nutr., 128(8), 1401-1408.
255. Zimmermann, M.B. and Köhrle, J. (2002) The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid, 12(10), 867-878.
256. Hess, S.Y. and Zimmermann, M.B. (2004) The effect of micronutrient deficiencies on iodine nutrition and thyroid metabolism. Int. J. Vitam. Nutr. Res., 74(2), 103-15.
257. Boyle, J.A.; Greig, W.R.; Fulton, S. and Dalakos, T.G. (1966) Excess dietary calcium and human thyroid function. J. Endocrinol., 34(4), 531-532.
258. Singh, N.; Singh, P.N. and Hershman, J.M. (2000) Effect of calcium carbonate on the absorption of levothyroxine. JAMA, 283(21), 2822-2825.
259. Singh, N.; Weisler, S.L. and Hershman, J.M. (2001) The acute effect of calcium carbonate on the intestinal absoprption of levothyroxine. Thyroid, 11(10), 967-971.
260. Bloomfield, R.A., Welsch, C.W., Garner, G.B. and Muhrer, M.E. (1961) Effect of dietary nitrate on thyroid function. Science, 134, 1690.
261. Clode, W.; Sobral, J.M. and Baptista, A.M. (1961) Bromine interference in iodine metabolism and its goitrogenic action. R. Pitt-Rivers (eds), Advances in Thyroid Research, Pergamon Press, New York, pp; 65.
262. Vobecký, M.; Babický, A.; Lener, J. and Svandová, E. (1996) Interaction of bromine with iodine in the rat thyroid gland at enhanced bromide intake. Biol. Trace Elem. Res., 54(3), 207-212.
263. Velický, J.; Titlbach, M.; Dusková, J.; Vobecký, M.; Strbák, V. and Raska, I. (1997) Potassium bromide and the thyroid gland of the rat: morphology and immunohistochemistry, RIA and INAA analysis. Ann. Anat., 179(5), 421-431.
264. Galletti, P.M. and Joyet, G. (1958) Effect of fluorine on thyroidal iodine metaoblism in hyperthyroidism. J. Clin. Endocrinol. Metab., 18(10), 1102-1110.
265. Day, T.K. and Powell-Jackson, P.R. (1972) Fluoride water hardness, and endemic goiter. Lancet, 1(7761), 1135-1138.
266. Paley, K.R.; Sobel, E.S. and Yalow, R.S. (1958) Effect of oral and intravenous cobaltous chloride on thyroid function. J. Clin. Endocrinol. Metab., 18(8), 850-859 .
267. Stangl, G.I., Schwartz, F.J. and Kirchgessner, M. (1999) Cobalt deficiency effects on trace elements, hormones and enzymes involved in energy metabolsim in cattle. Int. J. Vitam. Nutr. Res., 69(2), 120-126.
268. Barceloux, D.G. and Cobalt. J. Toxicol. Clin. Toxicol., (1999), 37(2), 201-206.
269. Pimentel-Malaussena, E.; Roche, M. and Layrisse, M. (1958) Treatment of eight cases of hyperthyroidism with cobaltous chloride. J. Am. Med. Assoc., 167(14), 1719-1722.
270. Bach, I.; Braun, S.; Gati, T.; Kertai, P.; Sos, J. and Udvardy, A. (1961) Effect of rubidium on the thyroid. R. Pitt-Rivers (eds), Advances in Thyroid Research, Pergamon Press, New York, pp. 505.
271. Gupta, P. and Kar, A. (1998) Role of ascorbic acid in cadmiuminduced thyroid dysfunction and lipid peroxidation. J. Appl. Toxicol., 18(5), 317-320.
272. Paier, B.; Pavia, M.A. Jr; Hansi, C.; Noli, M.I.; Hagmuller, K. and Zaninovich, A.A. (1997) Cadmium inhibits the in vitro conversion of thyroxine to triiodothyronine in rat brown adipose tissue. Bull. Environ. Contam. Toxicol., 59(1), 164-170.
273. Gupta, P.; Chaurasia, S.S., Maiti, P.K. and Kar, A. (1997) Cadmium induced alterations in extrathyroidal conversion of thyroxine to triiodothyronine by type-I iodothyronine 5'-monodeiodinase in male mouse. Horm. Metab. Res., 29(3), 151-152.
274. Pousset, G.B.; Briere, J.; Berthezene, F.; Tourniare, J. and Devic, M. (1973) Myxoedeme au lithium. Ann. Endocrinol. (Paris), 34(5), 549-562.
275. Berens, S.C.; Bernstein, R.S.; Robbins, J. and Wolff, J. (1970) Antithyroid effects of lithium. J. Clin. Invest., 49(7), 1357-1367.
276. Spaulding, S.W.; Burrow, G.N., Bermudez, F. and Himmelhoch, J.M. (1972) The inhibitory effect of lithium on thyroid hormone release in both euthyroid and thyrotoxic patients. J. Clin. Endocrinol. Metab., 35(6), 905-911.
277. Carlson, H.E.; Tample, R. and Robbins, J. (1973) Effect of lithium on thyroxine disappearance in man. J. Clin. Endocrinol. Metab., 36(6), 1251-1254.
278. Lazarus, J.H. (1998) The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid, 8(10), 909-913.
279. Burman, K.D.; Diamond, R.C., Earll, J.M., Wright, F.D. and Wartofsky, L. (1976) Sensitivity to lithium in treated Graves' disease: Effects on serum T4, T3 and reverse T3. J. Clin. Endocrinol. Metab., 43(3), 606-613.
280. Blomqvist, N.; Lindstedt, G.; Lundberg, P.A. and Wålinder, J. (1977) No inhibition by Li+ of thyroxine monodeiodination to 3,5,3′-triiodothyronine and 3,3′,5′-triiodothyronine (reverse triiodothyronine). Clin. Chim. Acta., 79(2), 457-464 .
281. Linquette, M.; Lefebvre, J.; Van Parys, C. and Wemeau, J.L. (1978) Le lithium dans le traitement des thyrotoxicoses. Ann. Endocrinol. (Paris), 39(1), 15-21.
282. Shopsin, B.; Shenkman, L.; Blum, M. and Hollander, C.S. (1973) Iodine and lithium-induced hypothyroidism. Documentation of synergism. Am. J. Med., 55(5), 695-699.
283. Andersen, B.F. (1973) Iodide perchlorate discharge test in lithiumtreated patients. Acta Endocrinol. (Copenh)., 73(1), 35-42.
284. Berens, S.C., Wolff, J. and Murphy, D.L. (1970) Lithium concentration by the thyroid. Endocrinology, 87(5), 1085-1087.
285. Wolff, J.; Berens, S.C. and Jones, A.B. (1970) Inhibition of thyrotropin-stimulated adenyl cyclase activity of beef thyroid members by low concentration of lithium ion. Biochem. Biophys. Res. Commun., 39(1), 77-82.
286. Bhattacharyya, B. and Wolff, J. (1976) Stabilization of microtubules by lithium ion. Biochem. Biophys. Res. Commun., 73(2), 383-390.
287. Baumgartner, A.; Pinna, G.; Hiedra, L.; Gaio, U.; Hessenius, C.; Campos-Barros, A.; Eravci, M.; Prengel, H.; Thoma, R. and Meinhold, H. (1997) Effects of lithium and carbamazapine on thyroid hormone metabolism in rat brain. Neuropsychopharmacology, 16(1), 25-41.
288. Hahn, C.G.; Pawlyk, A.C.; Whybrow, P.C.; Gyulai, L. and Tejani-Butt, S.M. (1999) Lithium administration affects gene expression of thyroid hormone receptors in rat brain. Life Sci., 64(20), 1793-1802.
289. Lazarus, J.H.; John, R.; Bennie, E.H.; Chalmers, R.J. and Crockett, G. (1981) Lithium therapy and thyroid function: A long term study. Psych. Med., 11(1), 85-92.
290. Segal, R.L., Rosenblatt, S. and Eliasoph, I. (1973) Endocrine exophthalmos during lithium therapy of manic-depressive disease. N. Engl. J. Med., 289(3), 136-138.
291. Zimmermann, M.B.; Jooste, P.L.; Mabapa, N.S.; Schoeman, S.; Biebinger, R.; Mushaphi, L.F. and Mbhenyane, X. (2007) Vitamin A supplementation in iodine-deficient African children decreases thyrotropin stimulation of the thyroid and reduces the goiter rate. Am. J. Clin. Nutr., 86(4), 1040-1044.
292. Chandra, A.K.; Mukhopadhyay, S.; Lahari, D. and Tripathy, S. (2004) Goitrogenic content of Indian cyanogenic plant foods and their in vitro antithyroidal activity. Indian J. Med. Res., 119(5), 180-185.
293. Ferreira, A.C.; Neto, J.C.; da Silva, A.C.; Kuster, R.M. and Carvalho, D.P. (2006) Inhibition of thyroid peroxidase by Myrcia uniflora flavonoids. Chem. Res. Toxicol., 19(3), 351-355 .
294. McMillan, M.; Spinks, E.A. and Fenwick, G.R. (1986) Preliminary observations on the effect of dietary brussels sprouts on thyroid function. Hum. Toxicol., 5(1), 15-19.
295. Knudsen, N.; Bulow, I.; Laurberg, P.; Ovesen, L.; Perrild, H. and Jorgensen, T. (2002) Association of tobacco smoking with goiter in a low-iodine-intake area. Arch. Intern. Med., 162(4), 439-443.
296. Divi, R.L.; Chang, H.C. and Doerge, D.R. (1997) Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochem. Pharmacol., 54(10), 1087-1096.
297. Doerge, D.R. and Sheehan, D.M. (2002) Goitrogenic and estrogenic activity of soy isoflavones. Environ. Health Perspect., 110(Suppl 3), 349-353.
298. Hendler, S.S. and Rorvik, D.R. Eds. (2001) PDR for Nutritional Supplements. Montvale, Medical Economics Company, Inc.
299. VanWyk, J.J.; Arnold, M.B.; Wynn, J. and Pepper, F. (1959) The effect of a soybean producton thyroid function in humans. Pediatrics, 24, 752-760.
300. Chorazy, P.A.; Himelhoch, S.; Hopwood, N.J.; Greger, N.G. and Postellon, D.C. (1995) Persistent hypothyroidism in an infant receiving a soy formula: case report and review of the literature. Pediatrics, 96(1 Pt 1), 148-150.
301. Jabbar, M.A.; Larrea, J. and Shaw, R.A. (1997) Abnormal thyroid function tests in infants with congenital hypothyroidism: the influence of soy-based formula. J. Am. Coll. Nutr., 16(3), 280-282.
302. Bruce, B.; Messina, M. and Spiller, G.A. (2003) Isoflavone supplements do not affect thyroid function in iodine-replete postmenopausal women. J. Med. Food, 6(4), 309-316.
303. Persky, V.W.; Turyk, M.E.; Wang, L.; Freels, S.; Chatterton, R.Jr; Barnes, S.; Erdman, J.Jr; Sepkovic, D.W.; Bradlow, H.L. and Potter, S. (2002) Effect of soy protein on endogenous hormones in postmenopausal women. Am. J. Clin. Nutr., 75(1), 145-153.
304. Duncan, A.M.; Merz, B.E.; Xu, X.; Nagel, T.C.; Phipps, W.R. and Kurzer, M.S. (1999) Soy isoflavones exert modest hormonal effects in premenopausal women. J. Clin. Endocrinol. Metab., 84(1), 192-197.
305. Duncan, A.M., Underhill, K.E.; Xu, X.; Lavalleur, J.; Phipps, W.R. and Kurzer, M.S. (1999) Modest hormonal effects of soy isoflavones in postmenopausal women. J. Clin. Endocrinol. Metab., 84(10), 3479-3484.
306. Bell, D.S. and Ovalle, F. (2001) Use of soy protein supplement and resultant need for increased dose of levothyroxine. Endocr. Pract., 7(3), 193-194.
307. Munro, I.C.; Harwood, M.; Hlywka, J.J.; Stephen, A.M.; Doull, J.; Flamm, W.G. and Adlercreutz, H. (2003) Soy isoflavones: a safety review. Nutr. Rev., 61(1), 1-33.
308. Fletcher, R.J. (2003) Food sources of phyto-oestrogens and their precursors in Europe. Br. J. Nutr., 89(Suppl 1), S39-S43.
309. Ho, S.C.; Woo, J.L.; Leung, S.S., Sham, A.L.; Lam, T.H. and Janus, E.D. (2000) Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. J. Nutr., 130(10), 2590-2593.
310. Arai, Y.; Watanabe, S.; Kimira, M.; Shimoi, K.; Mochizuki, R. and Kinae, N. (2000) Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J. Nutr., 130(9), 2243-2250.
311. de Kleijn, M.J.; van der Schouw, Y.T.; Wilson, P.W.; Adlercreutz, H.; Mazur, W.; Grobbee, D.E. and Jacques, P.F. (2001) Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study(1-4). J. Nutr., 131(6), 1826-1832.
312. Strom, S.S.; Yamamura, Y.; Duphorne, C.M.; Spitz, M.R.; Babaian, R.J.; Pillow, P.C. and Hursting, S.D. (1999) Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr. Cancer, 33(1), 20-25.
313. van der Hooft, C.S.; Hoekstra, A.; Winter, A.; de Smet, P.A. and Stricker, B.H. (2005) Thyrotoxicosis following the use of ashwagandha. Ned Tijdschr Geneeskd, 149(47), 2637-2638.
314. Al-Qarawi, A.A.; Al-Damegh, M.A. and Elmougy, S.A. (2002) Effect of freeze dried extract of Olea europaea on the pituitary-thyroid axis in rats. Phytotherapy Res., 16(3), 286-287.